Bok
06-04-2013, 07:20 PM
The announcement last month of a long-awaited breakthrough in stem-cell research -- the creation of stem-cell lines from a cloned human embryo -- has revived interest in using embryonic stem cells to treat disease. But US regulations mean that many researchers will be watching those efforts from the sidelines.
[More] (http://www.scientificamerican.com/article.cfm?id=scientists-chafe-at-restrictions-on-new-stem-cell-lines)
http://ads.pheedo.com/img.phdo?p=1 (http://ads.pheedo.com/click.phdo?p=1)http://tags.bluekai.com/site/5148http://insight.adsrvr.org/track/evnt/?ct=0:5wz49e9&adv=wouzn4v&fmt=3
More... (http://www.scientificamerican.com/article.cfm?id=scientists-chafe-at-restrictions-on-new-stem-cell-lines)
[More] (http://www.scientificamerican.com/article.cfm?id=scientists-chafe-at-restrictions-on-new-stem-cell-lines)
http://ads.pheedo.com/img.phdo?p=1 (http://ads.pheedo.com/click.phdo?p=1)http://tags.bluekai.com/site/5148http://insight.adsrvr.org/track/evnt/?ct=0:5wz49e9&adv=wouzn4v&fmt=3
More... (http://www.scientificamerican.com/article.cfm?id=scientists-chafe-at-restrictions-on-new-stem-cell-lines)